Carcinoma In Situ — Trials

Carcinoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

274 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 72
Recruiting: 35
Ph III recruiting: 4
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (41)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03182959	Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer	completed	Early Phase 1	6	University of ArizonaOTHER	1	Jun 21, 2021	clinicaltrials
NCT01753908	Broccoli Sprout Extract in Treating Patients With Breast Cancer	completed	Early Phase 1	30	Roswell Park Cancer InstituteOTHER	1	Oct 31, 2019	clinicaltrials